Home

April 5, 2021
April 5, 2021

Regulatory considerations for cellular and gene therapy products in EU and US: A comparative analysis

Do you like it?
View more
March 9, 2021
March 9, 2021

Classification of cellular therapy and gene therapy (CGT) products: How regulators are working with industry

Do you like it?
View more
March 8, 2021
pharmacovigilance consulting services
March 8, 2021

End-to-end pharmacovigilance support for a UK-based pharmaceutical company

APCER’s Pharmacovigilance (PV) team supported a client’s expansion into new …
Do you like it?
View more
March 8, 2021
March 8, 2021

Setting up Agile PV operations for a US based Pharma company

APCER’s Pharmacovigilance (PV) team helped a biotech pharmaceutical company with …
Do you like it?
View more
March 8, 2021
end to end pharmacovigilance
March 8, 2021

Enabling global expansion by establishing an integrated PV system

APCER helped a global pharmaceutical company in establishing a collaborative …
Do you like it?
View more
January 10, 2021
January 10, 2021

Quality Assurance services

Our team of experienced auditors help the bio-pharma companies achieve …
Do you like it?
View more
January 6, 2021
January 6, 2021

APCER Factsheet

Snapshot of end-to-end Safety services offered by APCER Life Sciences. …
Do you like it?
View more
November 5, 2020
November 5, 2020

Human medicinal products containing nitrosamine impurities: Regulatory landscape in the United States and the European Union

Do you like it?
View more